Zealand Pharma has a total of 1820 patents globally, out of which 882 have been granted. Of these 1820 patents, more than 49% patents are active. The United States of America is where Zealand Pharma has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Zealand Pharma.
Zealand Pharma was founded in 2002. Zealand Pharma AS is a biotechnology company that creates and develops peptide-based medicines. Their work focuses on finding new treatments for serious metabolic and gastrointestinal conditions. The company is advancing several promising drug candidates through clinical development. Its research aims to provide better treatment options for patients with unmet medical needs.
The company has also licensed a peptide program to Boehringer Ingelheim, involving a once-weekly dual-acting GLP-1/glucagon agonist currently in early clinical development for obesity and/or Type 2 diabetes.
Do read about some of the most popular patents of Zealand Pharma which have been covered by us in this article and also you can find Zealand Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Zealand Pharma patent portfolio.
How many patents does Zealand Pharma have?
Zealand Pharma has a total of 1820 patents globally. These patents belong to 163 unique patent families. Out of 1820 patents, 895 patents are active.
How Many Patents did Zealand Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Zealand Pharma Applications Filed | Zealand Pharma Patents Granted |
| 2025 | 16 | 39 |
| 2024 | 61 | 54 |
| 2023 | 84 | 33 |
| 2022 | 99 | 36 |
| 2021 | 106 | 99 |
| 2020 | 62 | 78 |
| 2019 | 68 | 61 |
| 2018 | 83 | 64 |
| 2017 | 101 | 50 |
| 2016 | 80 | 64 |
How many Zealand Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Zealand Pharma File in Different Countries?
Countries in which Zealand Pharma Filed Patents
| Country | Patents |
| United States of America | 187 |
| Japan | 131 |
| Europe (EPO) | 125 |
| Canada | 80 |
| China | 72 |
| Australia | 70 |
| Mexico | 61 |
| Hong Kong (S.A.R.) | 61 |
| Israel | 55 |
| Austria | 55 |
| Germany | 54 |
| Brazil | 51 |
| New Zealand | 50 |
| India | 48 |
| South Africa | 48 |
| Singapore | 47 |
| Taiwan | 43 |
| Spain | 39 |
| Chile | 31 |
| Eurasia | 28 |
| Denmark | 27 |
| Korea (South) | 27 |
| Russia | 24 |
| United Kingdom | 22 |
| Argentina | 20 |
| Indonesia | 18 |
| Viet Nam | 17 |
| Philippines | 17 |
| Norway | 16 |
| Malaysia | 15 |
| Poland | 14 |
| Peru | 14 |
| Africa | 13 |
| Ukraine | 11 |
| Colombia | 11 |
| Portugal | 9 |
| Italy | 9 |
| Saudi Arabia | 9 |
| Hungary | 8 |
| Cyprus | 8 |
| Slovenia | 7 |
| Tunisia | 7 |
| Morocco | 6 |
| Slovakia | 5 |
| Ecuador | 5 |
| Estonia | 5 |
| Serbia | 4 |
| Uruguay | 4 |
| Malta | 3 |
| Thailand | 3 |
| Albania | 3 |
| Turkey | 3 |
| Croatia | 3 |
| Lithuania | 2 |
| Netherlands | 1 |
| Kenya | 1 |
| Gulf Cooperation Council | 1 |
| Montenegro | 1 |
| Georgia | 1 |
| Luxembourg | 1 |
| Honduras | 1 |
| Costa Rica | 1 |
| Czech Republic | 1 |
Where are Research Centers of Zealand Pharma Patents Located?
10 Best Zealand Pharma Patents
US6939324B2 is the most popular patent in the Zealand Pharma portfolio. It has received 272 citations so far from companies like Medtronic, Valeritas, Allergan.
Below is the list of 10 most cited patents of Zealand Pharma:
| Publication Number | Citation Count |
| US6939324B2 | 272 |
| WO2011006497A1 | 267 |
| WO2013164483A1 | 250 |
| WO2010070251A1 | 229 |
| US7027478B2 | 216 |
| WO2010070253A1 | 201 |
| WO2011160630A2 | 199 |
| WO2010070255A1 | 197 |
| WO2010070252A1 | 185 |
| US20050137536A1 | 151 |
What Percentage of Zealand Pharma US Patent Applications were Granted?
Zealand Pharma (Excluding its subsidiaries) has filed 239 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 134 have been granted leading to a grant rate of 70.53%.
Below are the key stats of Zealand Pharma patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Zealand Pharma?
| Law Firm | Total Applications | Success Rate |
| Clark Elbing Llp | 146 | 66.28% |
| Morgan Lewis & Bockius Llp Ph | 50 | 92.68% |
| Marshall Gerstein & Borun Llp | 15 | 100.00% |
| Wolf Greenfield & Sacks PC | 6 | 100.00% |
| Cooley Llp | 3 | 0.00% |
| Dann Dorfman Herrell & Skillman | 2 | 50.00% |
| Kirkpatrick & Lockhart Preston Gates Ellis Llp | 2 | 0.00% |
| Locke Lord Llp | 2 | 0.00% |
| Morse Barnes Brown & Pendleton PC | 2 | 100.00% |
| Pepper Norton Rose Fulbright Canada Llp | 2 | 100.00% |
| Ropes & Gray Llp | 2 | 50.00% |
| Birch Stewart Kolasch & Birch Llp | 1 | 100.00% |
| Finnegan Henderson Farabow Garrett & Dunner | 1 | 100.00% |
| Fish & Richardson PC | 1 | 0% |
| Fisherbroyles Llp | 1 | 100.00% |
What are Zealand Pharma key innovation segments?
What Technologies are Covered by Zealand Pharma?
The chart below distributes patents filed by Zealand Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Zealand Pharma thinks it’s important to protect particular technological inventions.
R&D Focus: How has Zealand Pharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Zealand Pharma?
